These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3905096)

  • 1. Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma.
    Larue C; Gueraud V; Rivat C
    Clin Exp Immunol; 1985 Oct; 62(1):217-24. PubMed ID: 3905096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific removal of antibody by extracorporeal circulation over antigen immobilized in collodion-charcoal.
    Terman DS; Tavel T; Petty D; Racic MR; Buffaloe G
    Clin Exp Immunol; 1977 Apr; 28(1):180-8. PubMed ID: 862246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific adsorption of circulating antibodies by extracorporeal plasma perfusions over antigen coated collagen flat-membranes: applications to systemic lupus erythematosus.
    El-Habib R; Laville M; Traeger J
    J Clin Lab Immunol; 1984 Nov; 15(3):111-7. PubMed ID: 6397594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific extraction of antigen in vivo by extracorporeal circulation over antibody immobilized in collodion-charcoal.
    Terman DS; Petty D; Ogden D; Pefley C; Buffaloe G
    J Immunol; 1976 Nov; 117(5 Pt.2):1971-5. PubMed ID: 62800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hypercholesteremia by extracorporeal immune adsorption].
    Riesen WF; Imhof C; Sturzenegger E; Descoeudres C; Mordasini R; Oetliker OH
    Schweiz Med Wochenschr; 1986 Jan; 116(1):8-11. PubMed ID: 3511523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microporous microparticles designed as stable immunoadsorbents.
    Ubrich N; Rivat C; Vigneron C; Maincent P
    Biotechnol Bioeng; 1998 Jun; 58(6):581-6. PubMed ID: 10099295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific removal of bovine serum albumin (BSA) antibodies in vivo by extracorporeal circulation over BSA immobilized on nylon microcapsules.
    Terman DS; Tavel T; Petty D; Tavel A; Harbeck R; Buffaloe G; Carr R
    J Immunol; 1976 May; 116(5):1337-41. PubMed ID: 774981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies released from immunoadsorbents: effect of support, activation and elution conditions.
    Ubrich N; Rivat C
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Jan; 24(1):65-75. PubMed ID: 8714720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New method for the specific clearance of antibodies using antigens linked to a collagen film.
    El Habib R; Traeger J; Gautheron DC; Coulet PR
    Biomed Pharmacother; 1982; 36(6-7):302-7. PubMed ID: 6763880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
    Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
    Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.
    Stoffel W; Demant T
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):611-5. PubMed ID: 7017720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
    Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
    Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosorption of apolipoproteins B. Optimization of the method in an in vitro bench test].
    Regnault V; Rivat C; Marcillier P; Schooneman F; Michaely JP; Stoltz JF; Duran Franzini F
    Ann Med Interne (Paris); 1988; 139 Suppl 1():77-9. PubMed ID: 3073687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of siliceous immunosorbents in hemosorption].
    Kulaev DV; Andrianova IP; Zuevskiĭ VV; Liukova TK; Silant'eva OV
    Patol Fiziol Eksp Ter; 1989; (5):62-5. PubMed ID: 2559390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel.
    Schenkein I; Bystryn JC; Uhr JW
    J Clin Invest; 1971 Sep; 50(9):1864-8. PubMed ID: 5564393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal removal of specific antibodies by hemoperfusion through the immunosorbent agarose-polyacrolein microsphere beads: removal of anti-bovine serum albumin in animals.
    Marcus L; Mashiah A; Offarim M; Margel S
    J Biomed Mater Res; 1984; 18(9):1153-67. PubMed ID: 6400018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
    Stoffel W; Borberg H; Greve V
    Lancet; 1981 Nov; 2(8254):1005-7. PubMed ID: 6118475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-based immunoadsorption as a therapeutic means.
    du Moulin A; Müller-Derlich J; Bieber F; Richter WO; Frei U; Müller R; Spaethe R
    Blood Purif; 1993; 11(3):145-9. PubMed ID: 8280435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies.
    Leventhal JR; John R; Fryer JP; Witson JC; Derlich JM; Remiszewski J; Dalmasso AP; Matas AJ; Bolman RM
    Transplantation; 1995 Jan; 59(2):294-300. PubMed ID: 7839454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.